Episode Details
Back to Episodes#66: Mary Simmons & John McDermott — Are Peptides the Cure Big Pharma Doesn’t Want?
Description
This week on "The Ultimate Assist", John Stockton and Ken Ruettgers sit down with peptide experts Mary Simmons and John McDermott for a deep dive into one of the most talked-about—and controversial—areas of modern health.
Peptides, they explain, are naturally occurring signaling molecules in the body that regulate everything from metabolism and healing to hormone balance and cellular repair. But despite their potential, many of these compounds exist in what Simmons describes as a “gray market”—caught between growing demand and limited regulatory approval.
The conversation explores:
- Why peptides have been difficult for pharmaceutical companies to patent
- Claims that regulatory agencies may be relying on incomplete or biased information
- The rise of GLP-1 weight loss drugs—and whether they’re addressing symptoms instead of root causes
- How peptides may support healing, recovery, metabolism, and inflammation at a cellular level
Simmons and McDermott also share insights from years of experience in bodybuilding and endurance sports, where peptide use has quietly existed for over a decade—often ahead of mainstream awareness.
The discussion expands into a broader look at modern health challenges, including:
- The role of toxins, pesticides, and environmental stressors
- Why metabolic dysfunction and insulin resistance are rising
- And whether current medical approaches are truly solving the problem—or just managing it
At its core, this episode asks:
Are we overlooking powerful tools for healing because they don’t fit the existing system?